Higher prevalence rates (19-69%) have been reported in specific populations, such as individuals living in crowded conditions (eg, institutions, communal living), individuals living in conditions with poor hygiene, and those traveling to developing countries. In 2014, new research was presented at the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) that questioned the pathogenicity of the parasite. Infection may occur at any age. The most common age at which infection has been reported in children is 5-10 years. Interestingly, E vermicularis (pinworm) infection can also occur in the same age group.
Symptoms: The most common type of symptoms are diarrhea, stomach pain, and stomach cramping. Loss of appetite and weight, nausea, and fatigue also are common. The infection does not spread from the intestines to other parts of the body. Treatment: Safe and effective usage of Anti-fungal drugs and hygienic maintenance helps in treating the infection.
Pathophysiology: Dientamoeba fragilis infection in children is common, and its incidence has increased since the introduction of more sensitive molecular techniques. There is no consensus on the optimal treatment. Current medical practice in the Netherlands is to treat symptomatic children with clioquinol or metronidazole. This study attempts to obtain more information about the clinical picture of D. fragilis infection in children and to evaluate responses to both antiparasitic drugs.